374 related articles for article (PubMed ID: 33572600)
21. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
Gunaratne PH
Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
[TBL] [Abstract][Full Text] [Related]
22. Dysregulated genes and miRNAs in the apoptosis pathway in colorectal cancer patients.
Slattery ML; Mullany LE; Sakoda LC; Wolff RK; Samowitz WS; Herrick JS
Apoptosis; 2018 Apr; 23(3-4):237-250. PubMed ID: 29516317
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
[TBL] [Abstract][Full Text] [Related]
24. Expression profile, molecular functions, and prognostic significance of miRNAs in primary colorectal cancer stem cells.
Fan CW; Lu R; Fang C; Zhang XL; Lv ZY; Li Y; Zhang H; Zhou ZG; Mo XM; Sun XF
Aging (Albany NY); 2021 Apr; 13(8):12067-12085. PubMed ID: 33793420
[TBL] [Abstract][Full Text] [Related]
25. Role of cancer stem cells in racial disparity in colorectal cancer.
Farhana L; Antaki F; Anees MR; Nangia-Makker P; Judd S; Hadden T; Levi E; Murshed F; Yu Y; Van Buren E; Ahmed K; Dyson G; Majumdar AP
Cancer Med; 2016 Jun; 5(6):1268-78. PubMed ID: 26990997
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA signatures: novel biomarker for colorectal cancer?
Luo X; Burwinkel B; Tao S; Brenner H
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1272-86. PubMed ID: 21551242
[TBL] [Abstract][Full Text] [Related]
27. MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.
Boo L; Ho WY; Ali NM; Yeap SK; Ky H; Chan KG; Yin WF; Satharasinghe DA; Liew WC; Tan SW; Ong HK; Cheong SK
Int J Biol Sci; 2016; 12(4):427-45. PubMed ID: 27019627
[TBL] [Abstract][Full Text] [Related]
28. MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study.
Chen E; Li Q; Wang H; Yang F; Min L; Yang J
Biomed Pharmacother; 2018 Oct; 106():1370-1377. PubMed ID: 30119209
[TBL] [Abstract][Full Text] [Related]
29. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
[TBL] [Abstract][Full Text] [Related]
30. Investigation of miRNA dysregulation and association with immune cell profile during malignant transformation of colorectal cells.
Ng L; Li X; Wan TM; Iyer D; Sin RW; Lo OS; Foo DC; Law WL
Eur J Surg Oncol; 2022 Jan; 48(1):245-252. PubMed ID: 34620510
[TBL] [Abstract][Full Text] [Related]
31. The NF-κB signalling pathway in colorectal cancer: associations between dysregulated gene and miRNA expression.
Slattery ML; Mullany LE; Sakoda L; Samowitz WS; Wolff RK; Stevens JR; Herrick JS
J Cancer Res Clin Oncol; 2018 Feb; 144(2):269-283. PubMed ID: 29188362
[TBL] [Abstract][Full Text] [Related]
32. Revolutionizing colorectal cancer treatment: unleashing the potential of miRNAs in targeting cancer stem cells.
Osei GY; Adu-Amankwaah J; Koomson S; Beletaa S; Ahmad MK; Asiamah EA; Smith-Togobo C; Abdul Razak SR
Future Oncol; 2023 Nov; 19(35):2369-2382. PubMed ID: 37970643
[TBL] [Abstract][Full Text] [Related]
33. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
34. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma.
Das PK; Islam F; Lam AK
Cells; 2020 Jun; 9(6):. PubMed ID: 32503256
[TBL] [Abstract][Full Text] [Related]
35. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
36. Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration.
Ngalame NN; Makia NL; Waalkes MP; Tokar EJ
Toxicol Appl Pharmacol; 2016 Dec; 312():11-18. PubMed ID: 26721309
[TBL] [Abstract][Full Text] [Related]
37. Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells.
Mamoori A; Gopalan V; Smith RA; Lam AK
Biol Cell; 2016 Mar; 108(3):51-64. PubMed ID: 26712035
[TBL] [Abstract][Full Text] [Related]
38. Investigating intra-tumor heterogeneity and expression gradients of miR-21, miR-92a and miR-200c and their potential of predicting lymph node metastases in early colorectal cancer.
Jepsen RK; Novotny GW; Klarskov LL; Christensen IJ; Høgdall E; Riis LB
Exp Mol Pathol; 2016 Oct; 101(2):187-196. PubMed ID: 27565378
[TBL] [Abstract][Full Text] [Related]
39. Identification of microRNAs and their Endonucleolytic Cleavaged target mRNAs in colorectal cancer.
Zhou F; Tang D; Xu Y; He H; Wu Y; Lin L; Dong J; Tan W; Dai Y
BMC Cancer; 2020 Mar; 20(1):242. PubMed ID: 32293320
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer.
Liu J; Li H; Sun L; Shen S; Zhou Q; Yuan Y; Xing C
Dig Dis Sci; 2019 Jun; 64(6):1523-1534. PubMed ID: 30604369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
